Park Ha Biological Technology Co

BYAH

Market cap $5.36M

Wuxi, China, June 23, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that the Company has established a comprehensive strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK), a company listed on The Stock Exchange of Hong Kong (“Cloud Factory”).

Wuxi, China, June 15, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), today announced the closing of its previously announced registered direct offering with several investors for the sale and purchase of an aggregate of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the “Class A Ordinary Shares”), and pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 200,000 Class A Ordinary Shares, at a combined purchase price of $1.50 per Class A Ordinary Share and Pre-Funded Warrant.

Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company's securities in a registered direct offering (the “Offering”) consisting of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the “Shares”), and pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 200,000 Class A ordinary shares (the “Warrant Shares”), at a combined purchase price of $1.50 per Share and Pre-Funded Warrant. The gross proceeds to the Company from this Offering are expected to be approximately $2.0 million.

Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that the Company has established a comprehensive strategic partnership with Star Plus Action (HK) Limited (“Star Plus Action”), a wholly-owned subsidiary of Star Plus Legend Holdings Limited (6683.HK), a company listed on The Stock Exchange of Hong Kong (“Star Plus Legend”). The two parties will integrate resources in the healthcare industry, skincare product development, celebrity IP management, and artificial intelligence technology to jointly advance the beauty and wellness sector, creating an innovative business model that combines AI technology, professional skincare services, and health maintenance. Their first collaborative smart product—the AI Nutritionist—has been launched as a pilot. Moving forward, both parties will accelerate the development and deployment of a full-chain intelligent service system, including AI-powered store managers and AI-driven professional skincare specialists, driving the digital transformation of the skincare and wellness industry.

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Park Ha Biological Technology Co. Ltd. (NASDAQ: BYAH) resulting from allegations that Park Ha Biological may have issued materially misleading business information to the investing public. So what: If you purchased Park Ha Biological securities you may be entitled to compensation without payment of any out of pocket fees or cos.

Wuxi, China, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH; the “Company” or “PHH”) announced that the Company will be changing its ticker symbol from “PHH” to “BYAH”. Effective on Tuesday October 28, 2025, the Company's ordinary shares will trade on Nasdaq under the new symbol “BYAH”.

Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) (the “Company”), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the closing of its initial public offering (the “Offering”) of 1,200,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $4.00 per ordinary share. The Ordinary Shares began trading on the Nasdaq Capital Market on December 27, 2024 under the ticker symbol “PHH.”

Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the "Company"), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the pricing of its initial public offering (the "Offering") of 1,200,000 ordinary shares at a public offering price of $4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on December 27, 2024 under the ticker symbol "PHH."